Makristathis A, Stauffer F, Feistauer S M, Georgopoulos A
University Clinic for Internal Medicine I, Clinical Department for Infectious Diseases and Chemotherapy, Vienna, Austria.
Infect Immun. 1993 May;61(5):1996-2002. doi: 10.1128/iai.61.5.1996-2002.1993.
The role of platelet-activating factor (PAF) as mediator of the endotoxin shock and endotoxin-dependent tissue injury has been examined. The ability of opsonized bacteria to stimulate the release of PAF from human polymorphonuclear neutrophil granulocytes was evaluated by measuring both the activity and the amount of the mediator released in the supernatant of the cell-bacteria reaction in vitro. There was no significant difference between gram-positive and gram-negative bacteria in the ability to release PAF from neutrophils. However, preincubation of the cells with the specific PAF receptor antagonist WEB 2170 decreased release of PAF from the cells. Furthermore, a possible protective effect of the PAF antagonist was examined during experimentally induced pneumonia with Klebsiella pneumoniae in NMRI mice. Oral treatment of mice with WEB 2170, followed by infection with the microorganisms, resulted in a considerable increase in the animals' survival (53 to 73%) compared with the control group (40%); this increase corresponded with a decrease in the CFU per gram of lung tissue. These findings indicate an important role of PAF in the pathogenesis of pneumonia in mice.
血小板活化因子(PAF)作为内毒素休克和内毒素依赖性组织损伤介质的作用已得到研究。通过测量体外细胞 - 细菌反应上清液中释放的介质的活性和量,评估了调理素化细菌刺激人多形核中性粒细胞释放PAF的能力。革兰氏阳性菌和革兰氏阴性菌从中性粒细胞释放PAF的能力没有显著差异。然而,用特异性PAF受体拮抗剂WEB 2170对细胞进行预孵育可减少细胞释放PAF。此外,在NMRI小鼠实验性诱导的肺炎克雷伯菌肺炎期间,研究了PAF拮抗剂的可能保护作用。用WEB 2170口服治疗小鼠,随后感染微生物,与对照组(40%)相比,动物存活率显著提高(53%至73%);这种提高与每克肺组织中菌落形成单位(CFU)的减少相对应。这些发现表明PAF在小鼠肺炎发病机制中起重要作用。